Korea-Japan National Cancer Centers Renew MOU for Cancer Conquest

The National Cancer Center Korea (NCCK) is strengthening its collaboration with Japan’s National Cancer Center (NCCJ) in the fight against cancer.

On the 13th, NCCK announced that it had renewed its Memorandum of Understanding (MOU) with NCCJ and hosted a Korea-Japan Cancer Research Seminar on the 14th.

The two institutions have been cooperating in human resources and technology since issuing a joint statement in 2001. Through two previous MOU agreements in 2016 and 2019, they have continued 25 years of cancer research collaboration. This third MOU renewal is expected to further strengthen cooperation in cancer research.

The MOU signing ceremony was attended by Hitoshi Nakagama, President of NCCJ; Koichi Mizushima, Japanese Ambassador to Korea; Yang Hangwang, President of NCCK, and other key representatives from both countries.

NCCK stated that this agreement, signed in 2025, which marks the 60th anniversary of Korea-Japan diplomatic relations, is expected to serve as an opportunity to further solidify bilateral cooperation in the healthcare sector.

Following the signing ceremony, the Korea-Japan Cancer Research Seminar featured discussions across three sessions: basic research, cancer management, and clinical research, where the latest research achievements and future collaboration strategies were explored.

President Yang Hangwang of NCCK stated, “Through this MOU renewal and the Korea-Japan Cancer Research Seminar, we aim to further solidify our partnership and leverage the strengths of both countries, which are globally recognized in cancer research, policy, and treatment. We will continue to work together toward the ultimate goal of conquering cancer.”